Company Filing History:
Years Active: 2007-2010
Title: Exploring the Innovations of Inventor Donna A. Bassolino
Introduction
Donna A. Bassolino is an accomplished inventor based in Hamilton, NJ. She has contributed significantly to the field of biotechnology with her innovative patents focusing on polynucleotides and their therapeutic applications. With two patents to her name, she has proven her commitment to advancing medical science.
Latest Patents
Her latest patents include:
1. **Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3**: This invention details the identification and cloning of two novel full-length human SLAP-2 variants, hSLAP-2v3 and hSLAP-2v4. These proteins are crucial for the negative regulation of intracellular T-cell signal transduction. The patented technology aims to explore the therapeutic potentials of these novel polynucleotides and polypeptides in treating immunological and inflammatory disorders, autoimmune diseases, pulmonary diseases, proliferative immune disorders, and cancer.
2. **Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01**: This invention provides novel polynucleotides encoding LSI-01 polypeptides alongside their fragments and homologues. It encompasses vectors, host cells, antibodies, and methods to produce these polypeptides. Furthermore, it outlines diagnostic and therapeutic applications related to various diseases, as well as screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides.
Career Highlights
Donna A. Bassolino is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Throughout her career, she has focused on research that bridges the gap between scientific discovery and practical therapeutic solutions.
Collaborations
She has collaborated with noted researchers and colleagues such as Thomas C. Nelson and Jian Chen, enhancing her work's depth and scope. These collaborations are instrumental in fostering an environment of innovation and knowledge exchange essential for groundbreaking developments in her field.
Conclusion
Donna A. Bassolino exemplifies the spirit of innovation within biotechnology. Her patents reflect a deep understanding of complex biological processes and have the potential to impact medical therapies significantly. Through her work at Bristol-Myers Squibb and collaborations with talented colleagues, she continues to pave the way for advancements in health and medicine.